HealthRx.com

Jardiance HSA/FSA Eligibility and Submission: Everything You Need to Know in 2026

Prescription access and medication affordability image for Jardiance HSA/FSA Eligibility and Submission: Everything You Need to Know in 2026
Clinical image for TrimRx Prescription Process: How the Intake Works, What You Get, and Whether It's Worth It Image: HealthRX.com custom clinical image

At a glance

  • HSA/FSA eligible / Yes, prescription drugs qualify under IRS Publication 502
  • Jardiance list price (2026) / Approximately $648, $660 per 30-day supply
  • Boehringer Ingelheim Savings Card maximum benefit / Up to $150/month (commercially insured, not government-plan patients)
  • Lowest possible monthly out-of-pocket (stacked programs) / As low as $10/month for eligible patients
  • Key IRS rule / Must be prescribed by a licensed clinician; OTC drugs need a prescription to qualify
  • EMPEROR-Reduced trial (N=3,730) / Empagliflozin cut CV death or HF hospitalization by 25% vs. Placebo
  • EMPA-KIDNEY trial (N=6,609) / Empagliflozin reduced kidney disease progression or CV death by 28% vs. Placebo
  • FDA approvals covered / T2DM (2014), HFrEF (2021), HFpEF (2022), CKD (2023)
  • Submission method / Pharmacy swipe (auto-adjudication) or manual reimbursement with itemized receipt

Is Jardiance HSA/FSA Eligible?

Jardiance is HSA and FSA eligible because it is a prescription drug, and prescription drugs are qualified medical expenses under IRS Publication 502. The IRS defines a qualified medical expense as one that diagnoses, cures, mitigates, treats, or prevents disease. Empagliflozin has FDA-approved indications for type 2 diabetes, heart failure, and chronic kidney disease, three conditions that clearly meet this definition. Pay at the pharmacy counter with your HSA debit card or FSA card and no special paperwork is needed at the point of sale.

The IRS Rule Behind HSA/FSA Drug Coverage

IRS Publication 502 governs what counts as a qualified medical expense for HSA, FSA, and HRA accounts. The full text is publicly available from the IRS. Prescription drugs are explicitly listed as eligible. Over-the-counter drugs purchased without a prescription have required a written prescription to qualify since the CARES Act of 2020, but Jardiance is always dispensed by prescription, so that rule does not create any additional hurdle here.

The prescribing clinician must be licensed in their state. A telehealth prescription from a board-certified physician counts, including prescriptions written through platforms like HealthRX.

What FDA Approvals Support Medical Necessity?

The FDA approved empagliflozin (Jardiance) for four indications: type 2 diabetes mellitus in 2014, heart failure with reduced ejection fraction in 2021, heart failure with preserved ejection fraction in 2022, and chronic kidney disease in 2023. Each of these is a diagnosable condition under ICD-10, and each prescription for these conditions is medically necessary by the clinical standard that supports FDA approval.


How to Use Your HSA or FSA Card for Jardiance

Using your account is straightforward. Most pharmacy benefit systems auto-adjudicate HSA and FSA cards, meaning the card recognizes the drug is eligible without any action from you.

Option 1: Swipe at the Pharmacy Counter

Present your HSA or FSA debit card at checkout. The pharmacy's point-of-sale system queries the card network's eligibility database (IIAS, Inventory Information Approval System). Jardiance will be flagged as a prescription drug and the transaction will approve automatically. Keep your pharmacy receipt; your plan administrator may request it during an audit.

Option 2: Pay Out-of-Pocket and Submit for Reimbursement

If you pay with a personal credit card, you can submit a reimbursement claim later. You will need:

  • An itemized pharmacy receipt showing the drug name (empagliflozin or Jardiance), the date of service, the prescribing provider, and the amount paid.
  • Your FSA or HSA plan's reimbursement form (available in your online account portal).
  • A copy of the prescription or the pharmacy label (some plans require this; check your summary plan description).

FSA reimbursements must be submitted before your plan's run-out period, which is typically 90 days after the plan year ends. HSA reimbursements have no statutory deadline, you can reimburse yourself years later as long as the expense occurred after the HSA was established, per IRS Revenue Procedure 2003-43.

Option 3: HRA Submission

Health Reimbursement Arrangements follow employer-defined rules rather than IRS Publication 502 alone, but most employer HRAs cover prescription drugs. Submit the same itemized receipt to your employer's HRA administrator. Because HRA rules vary, confirm drug coverage directly with your HR department or plan documents before assuming eligibility.


What Jardiance Costs Without Insurance, And Why It Matters for HSA/FSA Sizing

The retail (cash) price of Jardiance 10 mg (30 tablets) runs approximately $648, $660 at major U.S. Pharmacies as of early 2026. The 25 mg strength carries a similar price. For patients paying full retail, whether uninsured or using an HDHP before meeting the deductible, this means an annual drug cost of approximately $7,800, $8,000 for Jardiance alone.

That figure is directly relevant to HSA contribution planning. The IRS set the 2026 HSA contribution limit at $4,300 for self-only coverage and $8,550 for family coverage (plus a $1,000 catch-up for enrollees age 55 or older). Stacking your full HSA contribution against a single high-cost medication like Jardiance, especially during the deductible phase, is a concrete tax strategy worth discussing with a financial planner.


How to Get Jardiance Cheaper: Every Savings Program in 2026

Prescription prices are not fixed. Several independent programs can reduce what you pay, and some can be combined with HSA/FSA payment.

Boehringer Ingelheim Savings Card

Boehringer Ingelheim and Lilly offer a co-pay savings card for Jardiance. As of 2026, eligible commercially insured patients may pay as little as $10 per month, with the card covering up to $150 of the co-pay per fill. Eligibility requirements: you must have commercial (private) insurance, you cannot be enrolled in a federal or state government health program (Medicare, Medicaid, TRICARE, VA, CHIP), and you must be a U.S. Resident. The savings card is enrolled at the manufacturer's patient assistance portal.

Important tax note: if your insurance covers Jardiance and you use a manufacturer co-pay card to pay your remaining cost-share, you generally cannot then reimburse yourself from an HSA for the same dollar amount. The IRS prohibits double-dipping on tax-favored accounts. You may reimburse the portion you actually paid out of pocket after the co-pay card is applied, but not the portion covered by the card.

Patient Assistance Programs

Patients who lack insurance or whose income falls below program thresholds may qualify for free or deeply discounted Jardiance through the BI Cares Foundation patient assistance program. Income guidelines change annually; the current threshold is typically at or below 400% of the federal poverty level. Applications require proof of income, a prescription, and confirmation that you do not have insurance covering Jardiance.

Pharmacy Discount Cards (GoodRx, RxSaver, Costco)

GoodRx and similar pharmacy discount programs can bring the cash price of Jardiance down to the range of $450, $550 at certain pharmacies, depending on location and negotiated rate. These are not insurance; they are negotiated discount agreements. You can pay the discounted price with your HSA debit card. The pharmacy discount replaces the insurance billing, so the price you actually pay is the HSA-eligible amount.

90-Day Supply Fills

Mail-order and 90-day retail fills typically cost less per tablet than a 30-day fill. Many insurers set the 90-day co-pay at 2x rather than 3x the 30-day co-pay. Paying a 90-day supply with your HSA card is fully eligible, the entire amount counts as a qualified medical expense.


The Clinical Evidence That Supports Long-Term Jardiance Use

Paying for a chronic medication from an HSA or FSA makes the most financial sense when the drug has clear, durable efficacy. Empagliflozin does. Three large randomized controlled trials define the benefit picture.

EMPA-REG OUTCOME: Cardiovascular Death in Type 2 Diabetes

The EMPA-REG OUTCOME trial (N=7,020) published in the New England Journal of Medicine in 2015 randomized patients with type 2 diabetes and high cardiovascular risk to empagliflozin 10 mg, empagliflozin 25 mg, or placebo. Empagliflozin reduced the composite of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke by 14% (HR 0.86, 95% CI 0.74 to 0.99, P<0.001 for non-inferiority; P=0.04 for superiority). CV death alone fell by 38%. These findings supported the 2021 ADA Standards of Medical Care recommendation that patients with T2DM and established cardiovascular disease receive an SGLT2 inhibitor with proven CV benefit.

EMPEROR-Reduced: Heart Failure with Reduced Ejection Fraction

EMPEROR-Reduced (N=3,730) showed empagliflozin 10 mg reduced the composite of CV death or hospitalization for heart failure by 25% vs. Placebo (HR 0.75, 95% CI 0.65 to 0.86, P<0.001) over a median of 16 months. The 2022 ACC/AHA/HFSA Heart Failure Guideline gave SGLT2 inhibitors a Class I recommendation for symptomatic HFrEF regardless of diabetes status.

EMPA-KIDNEY: Chronic Kidney Disease

The EMPA-KIDNEY trial (N=6,609) published in 2023 enrolled patients with CKD (eGFR 20 to 44 mL/min/1.73m2 regardless of albuminuria, or eGFR 45 to 89 with elevated albuminuria). Empagliflozin 10 mg reduced the composite of kidney disease progression or CV death by 28% (HR 0.72, 95% CI 0.64 to 0.82, P<0.001). The FDA granted approval for the CKD indication in February 2023 based substantially on this trial.

These outcomes matter for the HSA/FSA conversation because they establish that chronic Jardiance use reduces hospitalizations, hospitalizations that would themselves generate large HSA/FSA-eligible expenses.


ADA and ACC Guideline Context for Prescribing Decisions

ADA Standards of Medical Care 2025

The ADA Standards of Medical Care in Diabetes 2025 recommends SGLT2 inhibitors for adults with type 2 diabetes who have or are at high risk for atherosclerotic cardiovascular disease, heart failure, or CKD. The guideline specifically notes empagliflozin as one of the agents with outcome data in each of these populations. This means a valid prescription for Jardiance in these contexts meets the IRS standard of "treating or preventing disease" without ambiguity.

ACC/AHA Heart Failure Guideline 2022

The 2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure states: "In patients with HFrEF who remain symptomatic on optimally tolerated doses of guideline-directed medical therapy, SGLT2 inhibitors are recommended to reduce HF hospitalizations and cardiovascular mortality." This Class I, Level A recommendation applies regardless of whether the patient has diabetes.

The practical implication: a prescriber writing Jardiance for heart failure under this guideline is generating a prescription that is both medically necessary and unambiguously HSA/FSA eligible, no prior authorization letter or letter of medical necessity is needed for the HSA/FSA eligibility question itself.


Common HSA/FSA Submission Errors to Avoid

Several documentation mistakes cause rejected claims or IRS audit flags. Knowing them in advance saves time.

Missing Drug Name on Receipt

Some pharmacy receipts print only the brand name, others only the generic. Either is acceptable, but the drug name must appear somewhere on the receipt. If your pharmacy prints a cash register tape that shows only a price and a transaction number, request an itemized pharmacy printout, any chain pharmacy can generate one on demand.

Using an Expired FSA Card

FSA cards expire with the plan year (plus any grace period). Attempting to charge Jardiance to a card after the run-out deadline fails at the point of sale. Check your card's expiration date and your plan's run-out deadline, typically shown in your FSA portal.

Reimbursing a Co-Pay Card Portion

As described in the savings card section above, the amount covered by a manufacturer's co-pay assistance card is not a qualified medical expense you paid. Only the dollar amount you actually paid comes out of your HSA or FSA. Attempting to reimburse the co-pay card's contribution from an HSA violates IRS rules and could trigger account disqualification.

Submitting Without a Valid Prescription Date

The IRS requires that the medical expense be incurred after the HSA was established and after the HDHP coverage effective date. If you started an HDHP on January 1 and opened the HSA on February 1, any Jardiance paid for in January is not reimbursable from that HSA, even if you submit in March. Date accuracy is the single most common audit trigger.


Letter of Medical Necessity: When You Need One (and When You Don't)

For HSA and FSA purposes, prescription drugs do not require a separate Letter of Medical Necessity (LMN). The prescription itself establishes medical necessity. LMNs are typically required for FSA claims involving durable medical equipment, certain OTC items, or procedures that sit in a gray zone of eligibility (for example, special medical food). Jardiance does not sit in any gray zone.

Where an LMN may still be useful: some employer FSA plan administrators request one if they flag an unusual expense during an audit. If your plan administrator contacts you, a one-paragraph note from your prescribing clinician citing the relevant diagnosis code (E11.x for type 2 diabetes, I50.x for heart failure, N18.x for CKD) resolves the query quickly.


Stacking HSA/FSA With Other Savings: A Practical Decision Tree

Patients ask whether these programs can be combined. The answer depends on insurance status.

Scenario A: Commercially insured, Jardiance covered on formulary. Use the Boehringer Ingelheim Savings Card to reduce your co-pay. Pay the remaining co-pay with your HSA or FSA card. The net out-of-pocket can reach $10 per month. You may not reimburse the savings card's share from your HSA.

Scenario B: Commercially insured, HDHP, pre-deductible. No insurance benefit applies until your deductible is met. Pay the full retail or GoodRx-negotiated price with your HSA card. The savings card from Boehringer Ingelheim may not apply when insurance isn't billing (check current program terms), so the GoodRx price plus HSA payment is often the lowest-cost route until the deductible is satisfied.

Scenario C: Uninsured. Pay GoodRx or similar negotiated price. Use HSA card if you have one. Apply for the BI Cares patient assistance program if income qualifies. You cannot use FSA funds if you lack employer-sponsored FSA coverage, but an individual HSA is available to anyone enrolled in a qualifying HDHP.

Scenario D: Medicare or Medicaid. Manufacturer co-pay cards are prohibited for government-program beneficiaries under federal anti-kickback statute. HSA contributions are also prohibited once Medicare Part A or B coverage begins. FSA accounts through a former employer's COBRA coverage remain accessible. Medicare Part D Extra Help (Low Income Subsidy) is the primary cost-reduction program for this group, the CMS Extra Help program is the starting point.


Empagliflozin Dosing and What You Will Actually Fill

Understanding what strength your prescriber writes matters when estimating HSA/FSA spend.

Jardiance comes in 10 mg and 25 mg tablets, taken once daily in the morning regardless of food. The FDA-approved prescribing information recommends starting at 10 mg once daily for type 2 diabetes and increasing to 25 mg if additional glycemic control is needed and the patient tolerates the lower dose. For heart failure and CKD, clinical trials used 10 mg; the 25 mg dose is not routinely recommended for these indications based on current evidence.

Both strengths carry similar list prices, so a 10 mg prescription does not automatically cost less than a 25 mg prescription. Plan your HSA contributions accordingly.

Common adverse effects include urinary tract infections, genital mycotic infections, and volume depletion. The FDA label lists euglycemic diabetic ketoacidosis (eDKA) as a rare but serious risk, particularly in patients undergoing surgery or prolonged fasting; patients should hold empagliflozin at least 3 days before elective surgery. These events, if they result in emergency care, would generate additional HSA/FSA-eligible expenses, another reason to maintain a sufficient HSA balance.


How HealthRX Connects You to Jardiance and Savings Programs

HealthRX clinicians prescribe empagliflozin for FDA-approved indications following ADA Standards of Care 2025 and ACC/AHA Heart Failure Guideline 2022 criteria. After a consultation, our care team can send the prescription directly to your pharmacy of choice, including mail-order pharmacies that accept HSA/FSA cards and offer 90-day supplies.

Our patient coordinators can verify your Boehringer Ingelheim Savings Card eligibility at enrollment, walk you through the BI Cares application if you are uninsured, and provide an itemized superbill formatted to meet IRS documentation requirements. The combination of a telehealth prescription plus savings card stacking is available to commercially insured patients in states where HealthRX is licensed to prescribe.

Start the intake process at healthrx.com. After your prescriber writes the Jardiance order, request an itemized pharmacy receipt formatted for HSA/FSA submission at checkout, most major retail and mail-order pharmacies generate this automatically when an HSA card is presented.

Frequently asked questions

Can I use my HSA to pay for Jardiance?
Yes. Jardiance (empagliflozin) is a prescription drug and qualifies as a medical expense under IRS Publication 502. Present your HSA debit card at any pharmacy and the transaction will auto-approve. Keep the itemized receipt in case your plan administrator requests documentation.
Can I use my FSA to pay for Jardiance?
Yes. Prescription drugs are FSA-eligible under IRS Publication 502. Swipe your FSA card at the pharmacy or pay out of pocket and submit an itemized receipt for reimbursement before your plan's run-out deadline.
Does Jardiance require a Letter of Medical Necessity for HSA or FSA?
No. A valid prescription is sufficient for HSA and FSA reimbursement of prescription drugs. An LMN is only needed for certain durable medical equipment or gray-zone FSA items, not for an FDA-approved prescription medication.
Can I combine a Jardiance savings card with my HSA?
Partially. You can pay the out-of-pocket portion you actually owe after the savings card is applied with your HSA card. You cannot reimburse from your HSA the portion the savings card covered, that would be double-dipping on tax-favored benefits.
How much does Jardiance cost without insurance in 2026?
Approximately $648 to $660 per 30-day supply at retail. GoodRx and similar discount programs can bring this to around $450 to $550 depending on the pharmacy. Paying with an HSA card at the discounted price is fully eligible.
What is the Boehringer Ingelheim Jardiance savings card?
It is a manufacturer co-pay assistance card offered by Boehringer Ingelheim and Lilly. Eligible commercially insured patients (not on government programs) may pay as little as $10 per month, with the card covering up to $150 of co-pay per fill. Enroll at the manufacturer's patient assistance portal.
Can Medicare patients use an HSA for Jardiance?
Once Medicare Part A or B coverage begins, you can no longer make new HSA contributions. However, you may spend funds already in the HSA on qualified medical expenses including Jardiance. Manufacturer co-pay cards are not available to Medicare beneficiaries.
Is empagliflozin available as a generic?
As of early 2026, Jardiance does not have an FDA-approved generic in the United States. Boehringer Ingelheim holds market exclusivity. The savings card and patient assistance programs remain the primary cost-reduction tools until a generic enters the market.
Can I submit a 90-day supply of Jardiance for HSA reimbursement?
Yes. There is no per-fill quantity limit under IRS rules for HSA or FSA reimbursement of prescription drugs. A 90-day supply paid with your HSA card, or reimbursed with an itemized receipt, is fully eligible.
What documentation do I need to keep for Jardiance HSA expenses?
Keep the itemized pharmacy receipt showing the drug name, date, provider, and amount paid. Retain the prescription itself. Store these for at least three years after the tax year in which you took the HSA deduction, consistent with standard IRS audit look-back periods.
How do I get Jardiance cheaper if I am uninsured?
Three routes: (1) Apply for the Boehringer Ingelheim BI Cares patient assistance program if your income is at or below 400% of the federal poverty level. (2) Use a GoodRx-style discount card at a participating pharmacy. (3) Open an HSA if you are enrolled in a qualifying HDHP so your drug costs are paid with pre-tax dollars.
Does telehealth Jardiance prescription qualify for HSA or FSA?
Yes. A prescription written by a licensed clinician via telehealth is legally equivalent to an in-person prescription for HSA and FSA purposes. The IRS rules require a licensed prescriber, not an in-person encounter.

References

  1. Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373(22):2117-2128. https://www.nejm.org/doi/10.1056/NEJMoa1504720
  2. Packer M, Anker SD, Butler J, et al. Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med. 2020;383(15):1413-1424. https://www.nejm.org/doi/10.1056/NEJMoa2022190
  3. The EMPA-KIDNEY Collaborative Group. Empagliflozin in patients with chronic kidney disease. N Engl J Med. 2023;388(2):117-127. https://www.nejm.org/doi/10.1056/NEJMoa2204233
  4. American Diabetes Association Professional Practice Committee. Standards of Medical Care in Diabetes, 2025. Diabetes Care. 2025;48(Suppl 1):S1-S352. https://diabetesjournals.org/care/article/48/Supplement_1/S1/157536
  5. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 ACC/AHA/HFSA guideline for the management of heart failure. Circulation. 2022;145(18):e895-e1032. https://www.ahajournals.org/doi/10.1161/CIR.0000000000001063
  6. U.S. Food and Drug Administration. FDA approves Jardiance to reduce the risk of kidney disease progression and cardiovascular death in adults with chronic kidney disease. February 2023. https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-jardiance-reduce-risk-kidney-disease-progression-and-cardiovascular-death-adults
  7. U.S. Food and Drug Administration. Jardiance (empagliflozin) prescribing information. 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/204629s034lbl.pdf
  8. U.S. Food and Drug Administration. Jardiance NDA 204629 approval letter. 2014. https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/204629Orig1s000ltr.pdf
  9. U.S. Food and Drug Administration. Jardiance HFrEF supplement approval letter. 2021. https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/204629Orig1s026ltr.pdf
  10. Internal Revenue Service. Publication 502: Medical and Dental Expenses. 2025. https://www.irs.gov/publications/p502
  11. Internal Revenue Service. Revenue Procedure 2003-43. https://www.irs.gov/pub/irs-drop/rp-03-43.pdf
  12. Centers for Medicare and Medicaid Services. Medicare Part D Low Income Subsidy (Extra Help). https://www.cms.gov/Medicare/Prescription-Drug-Coverage/LowIncomeSubsidy
  13. Anker SD, Butler J, Filippatos G, et al. Empagliflozin in heart failure with a preserved ejection fraction. N Engl J Med. 2021;385(16):1451-1461. https://www.nejm.org/doi/10.1056/NEJMoa2107038
  14. American Diabetes Association. Standards of Medical Care, pharmacologic approaches to glycemic treatment. Diabetes Care. 2024;47(Suppl 1):S158-S178. https://diabetesjournals.org/care/article/47/Supplement_1/S158/153955
  15. Bhatt DL, Szarek M, Pitt B, et al. Sotagliflozin on cardiovascular and renal events in type 2 diabetes and CKD. N Engl J Med. 2021;384(2):129-139. https://www.nejm.org/doi/10.1056/NEJMoa2030186
  16. Cosentino F, Grant PJ, Aboyans V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases. Eur Heart J. 2020;41(2):255-323. https://academic.oup.com/eurheartj/article/41/2/255/5556890
Free2-min check·
Start assessment